| Comparative Bioavailability study of Diclofenac Topical solution (4%) vs Diclofenac Gel (1%) | A Randomized, Open Label, Balanced, Four Treatment, Four Period, Four-Sequence, Single Dose, Four way Crossover, Comparative Bioavailability Study of Testproduct T1: Dynapar QPS® (Diclofenac Diethylamine and Absolute Alcohol Non-Aqueous Topical Solution) (Dose: 1ml equivalent to 40 mg diclofenac sodium) and Testproduct T2: Dynapar QPS® (Diclofenac Diethylamine and Absolute Alcohol Non-Aqueous Topical Solution) (Dose: 2ml equivalent to 80 mg diclofenac sodium) ofTroikaa Pharmaceuticals Ltd., India with Reference product R1: Voveran Emulgel ofNovartis India Limited (Dose: 4 gm equivalent to 40 mg diclofenac sodium) andReference product R2: Voveran Emulgel of Novartis India Limited (Dose: 8 gmequivalent to 80 mg diclofenac sodium) in Normal, Healthy, Adult, Human Subjectsunder Fasting Conditions - NA | CTRI/2022/11/047283 |
| Study to evaluate the bioequivalence of Diclofenac diethylamine gel, 1.16% in subjects with Osteoarthritis Degenerative joint disease of the knee. | A Randomized, Double-Blind, Multicenter, Three-Arm, Placebo-Controlled, Parallel-Design,Bioequivalence Study with Clinical Endpoints comparing Diclofenac Diethylamine Gel 1.16% ofEncube Ethicals Private Limited, India with Voltaren Schmerzgel 11.6 mg/g (DiclofenacDiethylamine Gel 1.16%) of GlaxoSmithKline GmbH & Co. KG, 80258, Munich, Germany inPatients with Osteoarthritis (OA) of the Knee. - NIL | CTRI/2023/12/060871 |
| STUDY TO EVALUATE THE BIOEQUIVALENCE OF DICLOFENAC DIETHYLAMINE GEL, 2.32% (TARO PHARMACEUTICALS INC.) IN THE TREATMENT OF ACUTE SPRAIN OF LATERAL ANKLE. | A bioequivalence, multi-center, double-blind, randomized, placebo controlled, parallel-group study, comparing Diclofenac diethylamine gel, 2.32% (Taro Pharmaceuticals U.S.A., Inc.) to Voltaren Emulgel Extra Strength, 2.32% (Canadian Reference Product) and both active treatments to a placebo control in the treatment of acute sprain of lateral ankle. - NIL | CTRI/2023/10/058559 |
| To evaluate the efficacy and tolerability of diclofenac diethylamine 1.16% w/w gel in patients with acute localised muscle or joint injuries | Non-inferiority, Randomized, Double- blind Clinical Trial for Comparing the Efficacy and Tolerability of Diclofenac diethylamine 1.16% w/w gel of JAMP Pharma vs Voltaren Emulgel® (Diclofenac diethylamine 1.16% w/w) of GlaxoSmithKline Consumer Healthcare Inc., Canada in Patients with acute localized muscle or joint injuries | CTRI/2023/01/049202 |
| A trial to learn how a naproxen gel affects the level of pain and soreness and how safe it is compared to both a diclofenac diethylamine gel and a placebo in participants who have an injury to muscles, ligaments, or tendons in their legs or feet | Randomized, Controlled, Double-blind, Placebo-controlled, Multi-center Hypothesis-finding Trial to Compare the Efficacy and Safety of a 10% Naproxen Gel vs. a 2.32% Diclofenac Diethylamine Gel and Placebo in the Treatment of Acute Soft Tissue Injuries of the Lower Extremities | EUCTR2020-004343-92-DE |
| Voltaren Emulgel 2% Acute Ankle Sprain Non Inferiority Study | A Randomized, Double Blind, Multi Center, Active-controlled, 2 Treatment Arm, Parallel Group Non Inferiority Study to Evaluate the Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel Versus 1.16% Gel in Subjects With Acute Ankle Sprain | NCT04052620 |
| A study to compare the effectiveness of two different types of painkiller topical formulations | Prospective,open-label,randomized,parallel group,comparative clinical study of two topicalformulations of diclofenac diethylamine in the treatment of acute painful musculoskeletal conditions. | CTRI/2018/04/013316 |
| Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel in Patients With Acute Ankle Sprain | A Randomized, Double-blind, Multi-center, Vehicle-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel Applied Once or Twice Daily in Patients With Acute Ankle Sprain | NCT00573768 |
| A randomized, double-blind, multi-center, placebo-controlled, 3-treatment arm, parallel group study to evaluate the efficacy and safety of diclofenac diethylamine 2.32% gel applied twice or three times daily in patients with acute ankle sprain - | EUCTR2009-011571-71-DE |
| Evaluate the Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel Applied Twice or Three Times Daily in Patients With Acute Ankle Sprain | A Randomized, Double-blind, Multi-center, Placebo-controlled, 3-treatment Arm, Parallel Group Study to Evaluate the Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel Applied Twice or Three Times Daily in Patients With Acute Ankle Sprain | NCT00955513 |
| Multicenter randomized, double blind, 3 parallel arms, controlled trial of the clinical efficacy of topical 'Diclofenac 1%, gel' (diclofenac diethylamine 1.16%) for the treatment of osteoarthritis of the knee: equivalence of Generic product versus the Reference product and superiority versus placebo. - NA | Multicenter randomized, double blind, 3 parallel arms, controlled trial of the clinical efficacy of topical 'Diclofenac 1%, gel' (diclofenac diethylamine 1.16%) for the treatment of osteoarthritis of the knee: equivalence of Generic product versus the Reference product and superiority versus placebo. - NA | EUCTR2009-011785-28-FR |
| Efficacy, tolerability and safety of Z7202, a once daily diclofenac diethylamine medicated plaster in the local treatment of painful conditions. | Efficacy, tolerability and safety of Z7202, a once daily diclofenac diethylamine medicated plaster in the local treatment of painful conditions. Multi-centre, multinational, placebo- controlled, doubleblind, randomised, parallel-group study. | EUCTR2011-000725-69-LT |
| A randomized, double-blind, multi-center, vehicle-controlled, parallel group study to evaluate the efficacy and safety of diclofenac diethylamine 2.32% gel applied once or twice daily in subjects with acute ankle sprain | A randomized, double-blind, multi-center, vehicle-controlled, parallel group study to evaluate the efficacy and safety of diclofenac diethylamine 2.32% gel applied once or twice daily in subjects with acute ankle sprain | EUCTR2007-003797-25-DE |
| Clinical study to evaluate the efficacy and safety of diclofenac diethylamine 2.32% gel in subjects with knee osteoarthritis | A 4-week, randomized, double-blind, multi-center, vehicle-controlled, parallel group study to assess the efficacy and safety of diclofenac diethylamine 2.32% gel for the relief of signs and symptoms in patients with knee osteoarthritis | EUCTR2012-004024-38-DE |
| A Study to Characterize Diclofenac's Plasma and Knee Exposure After Application of Diclofenac Gel to the Knee of Subjects With Osteoarthritis That Have a Scheduled Arthroplasty | A Randomized, Double-Blind, Placebo-Controlled, Parallel Arm, Steady-State Pharmacokinetic and Disposition Study Characterizing Diclofenac's Plasma and Knee Exposure in Osteoarthritis (OA) Subjects Undergoing Scheduled Arthroplasty After Treatment With Diclofenac Diethylamine (DDEA) 2.32% Gel | NCT03497039 |
| To evaluate Safety and Efficacy of Diclofenac Diethylamine Gel with Capsaicin, Methyl Salicylate and Menthol In Painful Musculoskeletal Conditions. | A Multi-center, Prospective, Open-label, Randomized, Active-Controlled, Parallel-Group Clinical Study of Safety and Efficacy of Diclofenac Diethylamine Gel with Capsaicin, Methyl Salicylate and Menthol With Voveran® Thermagel� (Diclofenac Diethylamine Gel with Capsaicin, Methyl Salicylate and Menthol) In Painful Musculoskeletal Conditions. | CTRI/2013/06/003751 |
| A randomized, parallel control and multicenter clinical trial of evidence-based traditional Chinese medicine massage treatment VS external Diclofenac Diethylamine Emulgel for the treatment of knee osteoarthritis. | A randomized, parallel control and multicenter clinical trial of evidence-based traditional Chinese medicine massage treatment VS external Diclofenac Diethylamine Emulgel for the treatment of knee osteoarthritis. | ChiCTR1800014400 |
| Research on Clinical Efficacy of the Delivery of Diclofenac Diethylamine Emulgel via Nano Plum-blossom Needle in the Treatment of Acute Gouty Arthritis | Research on Clinical Efficacy of the Delivery of Diclofenac Diethylamine Emulgel via Nano Plum-blossom Needle in the Treatment of Acute Gouty Arthritis | ChiCTR-IOR-17012154 |
